Prexanil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prexanil

Quick Facts

Property Description
Active ingredient Perindopril (as tert-butylamine or arginine salt)
Form Oral tablets (Film-coated)
Pharmacological class Angiotensin-Converting Enzyme (ACE) Inhibitor
Common use Reduction of high blood pressure
Origin Synthetic

What Type of Medicine is Prexanil?

Prexanil is a prescription-only medication whose active ingredient is perindopril, a synthetic compound classified as an antihypertensive agent. This substance belongs to the major pharmacological group known as Angiotensin-Converting Enzyme (ACE) Inhibitors. This classification signifies that the drug is designed to interrupt the body's Renin-Angiotensin-Aldosterone System (RAAS), a key pathway controlling blood pressure. Perindopril acts as a prodrug, which the body converts into its active metabolite, perindoprilat, to exert its therapeutic effect after systemic administration. The efficacy of perindopril in managing elevated blood pressure is clinically recognized and supported by pharmacological studies.


Composition, Salt Form, and Delivery

The composition of Prexanil is a single-entity product based on the perindopril compound, supplied exclusively as oral tablets. The active ingredient may be formulated using different chemical configurations, specifically as the tert-butylamine salt or the arginine salt, which are common forms utilized in pharmaceutical production. These salt forms primarily impact the stability and specific absorption profile of the final film-coated tablets. Unlike some other ACE inhibitors, perindopril is often characterized by its long-acting properties, which support convenient, reliable oral intake.


General Benefit: Reducing Vascular Resistance

The general benefit of this medication is to effectively reduce vascular resistance throughout the body. By inhibiting the action of the Angiotensin-Converting Enzyme, the drug helps blood vessels relax and widen (vasodilation). This widening of the vessels is the foundational physiological action that leads to a measurable and sustained reduction of blood pressure, which is the core purpose of using this ACE inhibitor. A typical neutral use scenario for Prexanil is in the long-term management of essential hypertension in adults, consistently reducing the force exerted by blood flow.

What side effects are possible with Prexanil?

Possible Side Effects and Safety Information

The safety profile of perindopril (the active ingredient in Prexanil) is defined by regulatory authorities based on classified frequency and system-organ involvement, ranging from common, expected events to rare, serious adverse reactions.

Frequency-Classified Adverse Reactions

The most frequently reported effects, classified as Common (may affect up to 1 in 10 people), often involve the Respiratory, Thoracic, and Mediastinal Disorders (e.g., dry, persistent cough) and Nervous System Disorders (e.g., dizziness and headache). Other common effects include hypotension (low blood pressure) and gastrointestinal disturbances such as nausea, diarrhea, and dyspepsia.

Reactions classified as Uncommon (may affect up to 1 in 100 people) include swelling of the face, limbs, lips, tongue, or throat (Angioedema) and elevated blood potassium (Hyperkalemia). Very Rare events (may affect up to 1 in 10,000 people) include pancreatitis and hepatitis.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights several clinically significant safety concerns. The potential for Angioedema is a major documented risk due to the potential for fatal airway obstruction. Severe drops in blood pressure (Excessive Hypotension) may also occur, which can lead to cardiovascular events in high-risk patients. Furthermore, use during the second and third trimesters of pregnancy is strictly contraindicated due to the high risk of Fetal Toxicity (injury or death to the developing fetus).

Specific usage constraints exist, including a contraindication in patients with a history of ACE inhibitor-related angioedema or concurrent use with certain combination medications like sacubitril/valsartan. The label also specifies that special safety considerations apply to the elderly and those with renal impairment.

Overdose and Emergency Response

The official regulatory documentation for Prexanil (Perindopril) overdose outlines specific clinical manifestations and the required immediate emergency response. The most likely presentation of an overdose is marked hypotension, which is an excessive drop in blood pressure. This severe effect can lead to associated symptoms such as dizziness, lightheadedness, and syncope (fainting).

Regulatory information documents that an excessive blood pressure reduction carries the risk of life-threatening systemic outcomes, including circulatory shock and acute renal failure. Other severe potential complications listed include myocardial infarction or a cerebrovascular accident (stroke), particularly in at-risk patients. Laboratory findings requiring close monitoring include hyperkalemia (elevated potassium levels).

There is no specific antidote known for perindopril overdose; therefore, management is categorized as symptomatic and supportive treatment. The official label mandates that in case of suspected overdose or severe hypotension, the patient must be placed immediately in a supine position and should seek immediate medical attention. Specific procedures used in a clinical setting include intravenous infusion of physiological saline and the use of hemodialysis, as the active metabolite perindoprilat is removable from the body by this procedure. Population-specific considerations include documented risks for neonates exposed in utero.

Therapeutic Uses of Prexanil

What Prexanil Treats: Main Uses and Benefits

The medication is widely used to manage conditions related to the heart and blood vessels. Prexanil is commonly applied in conditions where functional stability becomes affected, such as essential hypertension (high blood pressure). It is also considered relevant for patients with established cardiovascular issues, including chronic stable heart failure and those with a history of vascular incidents like a myocardial infarction or stroke/TIA.

The medication is commonly used to help with sustained blood pressure control, which generally helps manage the symptoms linked to organ-specific functional stress. In heart failure, it supports a more manageable experience by addressing symptom clusters that may create noticeable physiological strain, such as breathlessness and fluid retention. In therapeutic contexts involving high risk, Prexanil contributes to easing the overall symptom load and may assist with managing the high-risk condition to support functional stability.


Quick Fact: Relief for Chronic Cardiovascular Burden
Prexanil is commonly used to manage the sustained physiological stress seen in chronic conditions like high blood pressure, stable heart failure, and post-event secondary prevention.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Prexanil? — Official Regulatory Information

The eligibility criteria for using Prexanil (perindopril) are strictly defined by regulatory authorities and based on specific population risks and prior health conditions.

Eligibility Scope Status Based on Regulatory Labels
Approved Age Group Adults (ge 18 years)
Pediatric Use Not Recommended (Safety and efficacy not established)
Pregnancy (2nd/3rd Trimester) Contraindicated (Risk of fetal injury or death)
Breastfeeding/Lactation Not Recommended (Drug is present in breast milk)
Severe Renal Impairment Not Recommended (Creatinine clearance < 30 mL/min)

Populations for whom use is Contraindicated (Must Not Use):

  • Patients with a history of angioedema (severe swelling) related to previous treatment with any ACE inhibitor or who have hereditary or idiopathic angioedema.
  • Women who are pregnant, especially during the second and third trimesters.
  • Patients using concomitant therapy with an Angiotensin Receptor Neprilysin Inhibitor (ARNI) (must not be administered within 36 hours of ARNI use).
  • Patients with diabetes mellitus who are receiving therapy with aliskiren.

Use is also permitted but requires caution and monitoring in older adults and in patients with liver disease or conditions that predispose them to significant hypotension.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prexanil, which contains the ACE inhibitor perindopril, has officially documented interaction patterns primarily concerning its effects on blood pressure, potassium levels, and its pharmacokinetic profile. This information is based strictly on regulatory labeling.

Formal Interaction Restrictions

Co-administration with sacubitril/valsartan is a formal contraindication due to a significantly increased risk of angioedema. A mandatory 36-hour wash-out period must separate the use of these two medicines. Co-administration with Aliskiren is contraindicated in patients with diabetes mellitus or moderate-to-severe renal impairment (GFR < 60 mL/min/1.73 m^2) due to risks of hyperkalemia, hypotension, and renal impairment. Furthermore, the use of perindopril is contraindicated with extracorporeal treatments where blood contacts negatively charged surfaces.

Documented Pharmacodynamic and Exposure Interactions

Combining perindopril with potassium-sparing diuretics (e.g., spironolactone) or potassium supplements is officially noted to increase the risk of hyperkalemia (elevated blood potassium). The co-administration of NSAIDs may lead to an attenuated hypotensive effect and an increased risk of acute deterioration of renal function. Perindopril decreases the renal clearance of lithium, resulting in increased serum lithium levels and potential toxicity. Regarding pharmacokinetics, the conversion of perindopril to its active metabolite, perindoprilat, is officially documented as being reduced by food.

Mechanism of Action

How Prexanil Works

Prexanil operates through a multi-faceted pharmacodynamic mechanism, primarily targeting key elements within both receptor-mediated and enzyme-mediated signaling pathways, resulting in the modulation of fundamental cellular processes. The agent is defined by its ability to modify specific molecular steps, influencing downstream effects within the central communication systems of the body.


Modulation of Receptor-Mediated Signaling

This domain describes Prexanil's principal interaction with specific receptor targets that govern intrinsic cellular responsiveness. By either initiating or suppressing these initial signaling sequences, the molecule influences the magnitude of mediator-driven signaling and alters the activity profiles of stimulated pathways.


Regulation of Key Enzyme Pathways

Prexanil engages mechanisms that influence the catalytic activity of distinct intracellular enzymes essential for signal transduction. This targeted pathway adjustment modifies early molecular steps, contributing to pathway activity modulation within systems that may otherwise exhibit dysregulated function.


Influence on Systemic Feedback Cascades

The drug is relevant in biological systems where multiple layers of pathway activation occur, specifically by modifying the feedback regulation within dominant signaling patterns. This engagement leads to predictable physiological adjustments, resulting in altered systemic signaling dynamics and influencing the resulting pathway activity.

Dosage and Administration Information

Prexanil is strictly administered via the oral route as a film-coated tablet, available in standard strengths such as 2 mg, 4 mg, and 8 mg. The medication is typically prescribed for once-daily use, although the maintenance dose for essential hypertension may be administered in two divided doses.

The dosing regimen is dependent on the specific condition. For essential hypertension, the standard initial dose is 4 mg once daily, with the typical maintenance range being 4 mg to 8 mg. The dose may be titrated upward over one-to-two-week intervals to a maximum of 16 mg per day. For stable coronary artery disease (SCAD), the protocol starts with 4 mg once daily for two weeks, followed by an increase to 8 mg once daily for maintenance.

The tablets can be taken with or without food, though food can reduce the absorption of the active metabolite, perindoprilat.

Specific dose adjustments are required for certain populations. For older adults (over 65 years), therapy often initiates with a lower daily dose, such as 4 mg for hypertension or a 2 mg starting dose for SCAD, with upward titration monitored closely. For patients with renal impairment (Creatinine Clearance ge 30 mL/min), the initial dose is reduced to 2 mg per day, and the daily dose should not exceed 8 mg. Use is not recommended for severe impairment. As a procedural usage principle, the dose of any concomitant diuretic should be considered for reduction prior to initiating perindopril therapy.

Recent Clinical Evidence

Prexanil: Recent Clinical Evidence

Core Efficacy in Hypertension

Prexanil, containing the active substance perindopril, is an angiotensin-converting enzyme (ACE) inhibitor. Research has consistently demonstrated its utility in the management of essential hypertension (high blood pressure) across diverse patient populations. Large, controlled clinical trials evaluating perindopril monotherapy typically reported significant mean reductions in both systolic and diastolic blood pressure measurements after approximately 12 weeks of treatment. A portion of patients achieved target blood pressure control (lt 140/90 mmHg) within this period, with further reductions observed upon dose adjustment.


Cardiovascular Risk Reduction and Long-Term Studies

Beyond blood pressure control, major randomized studies have examined the long-term impact of perindopril-based therapy on cardiovascular outcomes, particularly in patients with pre-existing stable coronary artery disease or a history of stroke. Evidence from these trials suggests a reduced risk of major cardiovascular events, including non-fatal myocardial infarction and cardiovascular mortality, when compared to placebo. This beneficial effect on risk reduction was observed over follow-up periods averaging several years.


Mechanism of Action and Safety Profile Evaluation

Studies suggest that perindopril is a prodrug that is metabolized to its active form, perindoprilat, which exerts its effect by blocking the ACE enzyme. This action is associated with the reduction of the vasoconstrictor angiotensin II and an increase in the vasodilator bradykinin, which subsequently assists in lowering blood pressure and cardiac workload. Regarding long-term use, perindopril has generally been studied and assessed for safety in patients with essential hypertension and stable coronary disease. Clinical trial data show that the most common adverse events include a persistent dry cough, which is characteristic of the ACE inhibitor class of medicines.

Key Studies & References

  1. NICE Guideline NG136: Hypertension in adults: diagnosis and management.

Frequently Asked Questions (FAQ)

Common questions about Prexanil (FAQ)

Q: How quickly should I expect to see a change after starting Prexanil?

A: While the active substance begins working relatively quickly, the full therapeutic effect of Prexanil in lowering blood pressure often requires time. According to official product information, achieving target blood pressure control is typically assessed after several weeks of continuous treatment, often around 12 weeks in clinical studies.

Q: Do I need to change my diet or lifestyle when taking Prexanil?

A: Prexanil is part of a comprehensive treatment plan for high blood pressure. Official guidance suggests that management often includes weight control and changes to diet, such as reducing sodium (salt) intake. A healthcare provider is best suited to discuss and determine which lifestyle changes may be beneficial for an individual.

Q: What happens if I miss a dose of Prexanil?

A: Product documentation generally states that if a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed one should be skipped entirely. The guidance advises against taking double or extra doses to compensate for a missed dose.

Q: What is the typical timeframe for getting used to Prexanil?

A: The body typically reaches stable levels of the active medication in the system after about three to six days of consistent dosing. It's during this initial period that common side effects, such as dizziness, may be most likely to occur as the body adjusts to the blood pressure changes.

Q: Has there been much research done on the long-term effects of Prexanil?

A: Yes, regulatory documents reference major randomized studies that have examined the long-term impact of Prexanil-based therapy. These trials specifically looked at its use over several years in patients with conditions like stable coronary artery disease to assess its effects on cardiovascular outcomes.

Q: Can Prexanil be used for conditions other than high blood pressure?

A: According to official indications, Prexanil is approved for more than just essential hypertension (high blood pressure). It is also used to help reduce the risk of major cardiovascular events, such as a heart attack, in patients with pre-existing stable coronary artery disease.

Q: Why is Prexanil often given with a diuretic?

A: A diuretic (or 'water pill') may be prescribed alongside Prexanil if blood pressure control is not fully achieved with Prexanil alone. Regulatory documents note that the dose of any concomitant diuretic may be considered for reduction before initiating perindopril therapy to help manage the risk of a significant drop in blood pressure.

Q: What should I do if I accidentally take two doses of Prexanil?

A: Taking more than the prescribed amount is considered an overdose, which can cause severe drops in blood pressure. If an overdose is suspected, the general safety guidance advises immediately seeking medical help by contacting a poison control center or emergency room.

Q: Can Prexanil affect my ability to drive or operate machinery?

A: Prexanil can have a minor to moderate influence on the ability to drive or operate machinery. Regulatory safety information advises caution, particularly if dizziness or fatigue is experienced. If these effects occur, general safety measures advise against driving or using tools/machinery.

Q: What is the purpose of the different strengths of Prexanil tablets?

A: The different tablet strengths (such as 2 mg, 4 mg, and 8 mg) allow a healthcare provider to titrate (gradually adjust) the dosage. This allows for the treatment to be tailored to the specific medical condition (e.g., hypertension versus stable coronary artery disease) and individual factors, such as age or kidney function.

Q: Can Prexanil interact with cold and flu medications?

A: Yes, there is a potential for interaction. Cold and flu medicines often contain ingredients that can affect blood pressure, such as sympathomimetic agents (decongestants) or non-steroidal anti-inflammatory drugs (NSAIDs). Using these together can potentially reduce the blood pressure-lowering effect of Prexanil and should be done with caution.

Q: Does alcohol intake change the effectiveness of Prexanil?

A: Regulatory warnings state that taking alcohol with Prexanil may lead to an adverse drug reaction. Alcohol can increase the blood pressure-lowering effect of the medication, potentially causing symptoms like excessive dizziness or lightheadedness.

Q: Is the brand name Prexanil the same as the generic name?

A: No, they are not the same. Prexanil is the brand name of the medication. The active ingredient within Prexanil is perindopril, which is the official generic name.

Q: Why is Prexanil only available by prescription?

A: Prexanil is a prescription-only medication because it is used to treat serious, chronic conditions like high blood pressure and coronary artery disease. Due to the need for medical supervision and the potential for serious side effects like angioedema, its use must be managed by a healthcare professional.

Q: Does Prexanil cause any sensitivity to the sun?

A: Official safety documents indicate that photosensitivity reactions (increased sensitivity to the sun) have been reported as an uncommon side effect of Prexanil. Precautionary measures may be advised when spending time in direct sunlight.

Q: Are there different types of Prexanil preparations (e.g., immediate or extended release)?

A: Regulatory information specifies that Prexanil is supplied exclusively as oral film-coated tablets. These tablets are designed to be long-acting, supporting the common once-daily dosing schedule, and are not categorized into separate immediate-release or extended-release formulations.

Q: Can Prexanil affect blood sugar levels in people without diabetes?

A: Yes, it can. Official safety documents list hypoglycemia (low blood sugar) as an uncommon metabolic adverse reaction. This is a consideration that may lead to monitoring in clinical practice.

Q: Does Prexanil have a 'withdrawal' effect if stopped suddenly?

A: Abruptly discontinuing Prexanil is not typically associated with a rapid increase in blood pressure; however, suddenly stopping any blood pressure medication can cause the blood pressure to go out of control. All changes to therapy should be made under the supervision of a healthcare provider.

Q: Can Prexanil be taken at any time of day, or is morning better?

A: Prexanil is typically prescribed for once-daily use. While the timing is generally flexible, taking it at the same time every day is key to maintaining stable blood pressure control. The specific timing of the dose should be followed as instructed by the prescribing clinician.

Q: Are headaches a common initial side effect when starting Prexanil?

A: Yes, headache is listed in regulatory information as a common side effect, meaning it may affect up to 1 in 10 people. Along with dizziness, these effects are often most likely to be noticed during the initial phase of treatment.

Q: Can Prexanil be crushed or split if I have trouble swallowing pills?

A: Official guidance related to pharmaceutical formulation suggests that perindopril tablets can be crushed and dispersed in water or mixed with soft food for patients who have difficulty swallowing whole pills. Consultation with a healthcare professional is standard practice before altering the tablet form.

Q: What are the most commonly reported side effects of taking Prexanil?

A: Based on clinical trial data, the most frequently reported side effects of Prexanil include a persistent dry cough, dizziness, and back pain. These effects, especially the cough, are characteristic of the ACE inhibitor class of medicines.

Q: Is a slight dizziness normal when first starting Prexanil?

A: Yes, dizziness is a common side effect that may affect up to 8% of patients and is generally considered a sign of low blood pressure. It is most likely to be seen when treatment is started or when the dose is increased as the body adjusts to the medication.

Q: Is Prexanil considered a long-term medication for high blood pressure?

A: Yes, Prexanil is indicated for the long-term management of essential hypertension (high blood pressure). Its use in reducing cardiovascular risk for patients with stable coronary artery disease is also intended for continuous, long-term therapy.

Q: Does Prexanil interact with supplements like potassium or magnesium?

A: Yes, official warnings exist for potassium supplements. Combining Prexanil with potassium supplements or potassium-sparing diuretics significantly increases the risk of developing hyperkalemia (elevated blood potassium), which requires monitoring. There are no specific regulatory warnings regarding magnesium.

Q: Are there any specific foods or drinks I should avoid while taking Prexanil?

A: It is advised to limit or avoid alcohol intake, as it can intensify the blood pressure-lowering effects of the drug. Additionally, while the medication can be taken with food, food may reduce the absorption of the active medicine, perindoprilat.

Q: Can I take Prexanil with food or should it be on an empty stomach?

A: Official administration instructions state the tablets can be taken with or without food. However, regulatory documents also note that food reduces the absorption of the active metabolite, perindoprilat, which may affect its overall effectiveness.

Q: Can I stop taking Prexanil if my blood pressure returns to normal?

A: No, high blood pressure is typically a chronic condition, and Prexanil is intended for continuous, long-term management to keep blood pressure stable. The medication should be continued as prescribed unless instructed otherwise by a healthcare provider.

Q: Can taking Prexanil cause me to feel tired or fatigued?

A: Yes, some patients in clinical studies have reported feeling unusual tiredness or weakness (sometimes called asthenia), which is categorized as a common side effect. Fatigue is listed among other effects in clinical reports.

Q: How long does Prexanil stay in your system after taking it?

A: The active form of the drug, called perindoprilat, has a prolonged terminal elimination half-life that can range from 30 to 120 hours. This long duration is what allows the medication to be effective with just a once-daily dose.

Q: Is it true that Prexanil can protect the heart or kidneys over time?

A: Clinical evidence supports that long-term use of Prexanil in patients with stable coronary artery disease helps to reduce the risk of serious cardiovascular events, such as non-fatal heart attacks and cardiovascular death. This is one of its core, proven benefits.

Q: Do users often report swelling in the ankles or face while on Prexanil?

A: A serious form of swelling known as Angioedema (swelling of the face, limbs, lips, or tongue) is a known but uncommon adverse reaction, affecting up to 1 in 100 people. If this occurs, it is a medical emergency. Swelling of the ankles or feet, while possible, is a symptom that warrants discussion with a healthcare provider.

How should Prexanil be stored and disposed of?

How to Store and Dispose of Prexanil

Official regulatory documents define mandatory requirements for the storage and disposal of Prexanil (perindopril) tablets.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with excursions up to 30 C.
Protection Tablets must be kept in a dry place, protected from moisture, and stored in the original, tightly closed container.
Child Safety The medication must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Prexanil must be disposed of according to local requirements. Regulatory labeling strictly mandates that the tablets must not be disposed of via wastewater or household waste to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prexanil found in:

A-Z Index: